Executive Vice President · BIOGEN INC. (BIIB)

Paul McKenzie

A named executive officer of BIOGEN in every fiscal year CompBrief holds from FY2017 to FY2018. Every figure below is printed as the company filed it and cited to the filing it came from.

Total disclosed compensation, FY2018

$5,665,896

Salary $630,455Stock awards $4,083,884

FY2017: $5,015,257

4th of 5 named executive officers at Biogen by FY2018 total.

5 named officers on file for BIOGEN, FY2018

Paul McKenzie’s pay file — $29

  • 2 fiscal years of pay, line by line
  • 3 equity grants, each cited to its filing
  • BIIB’s disclosed peer group of 15 companies

A PDF and a CSV sent to your email. Every row is cited to its filing.

One-time report. No refunds.

See an example →

Velarion Intel · free for 3 days · no card

See how BIOGEN’s whole pay program stands against its peers

  • BIOGEN’s company dashboard and its AI-written, board-ready brief, every figure cited to the filing
  • Peer-group intelligence, custom peer reruns and governance screens
  • Every other company we cover, with alerts when they file
Start my free trial on BIIB→

No card. Nothing is charged, and the trial ends on its own.

Compensation figures as of the proxy filed April 30, 2019 (DEF 14A).

Free

Get Paul McKenzie’s full pay file as a PDF — free

More than this page: up to 10 years of Paul’s pay history, a side-by-side peer comparison, and a one-page board summary — the whole file, yours now and by email.

Paul McKenzie compensation by year

BIOGEN Summary Compensation Table · all 2 fiscal years held
In US dollars, as BIOGEN reports it. Most recent year shaded. Totals are the company’s disclosed totals.
ComponentFY2017FY2018
Salary$600,433$630,455
Bonus$0$0
Stock awards$3,514,451$4,083,884
Option awards$0$0
Non-equity incentive$796,648$784,784
Pension and deferred compensation$2,471$12,367
All other$101,254$154,406
Total$5,015,257$5,665,896

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: BIOGEN INC. DEF 14A filed April 30, 2019, accession 0001193125-19-129278, and prior-year filings.

How this page was built: the BIOGEN INC. filed document, accession 0001193125-19-129278. Every figure is read from that document and cited to the page and table it appears in. Filed April 30, 2019.

$5.0M
$5.7M
FY17
FY18
SalaryNon-equity incentiveStock awardsAll other

Equity holdings

unvested awards at FY2018 year-end
TypeUnvested unitsValue at year-endExercise price
PSU9,470$2,849,712—
PSU4,674$1,406,500—
PSU4,108$1,236,179—
RSU3,875$1,166,065—
RSU3,790$1,140,487—
RSU1,820$547,674—
RSU1,194$359,298—
PSU848$255,180—
RSU616$185,367—

Per the Outstanding Equity Awards at Fiscal Year-End table in BIOGEN INC.'s FY2018 proxy; value at the fiscal year-end close, as the company printed it.

BIOGEN’s named executive officers, FY2018

as the company reported each
Named executive officerRoleFY2018 total
Michel VounatsosChief Executive Officer$16,168,646
Michael EhlersFormer Executive Vice President Research & Development$7,046,651
Susan AlexanderExecutive Vice President, Chief Legal Officer and Secretary$6,353,784
Paul McKenzie · this pageExecutive Vice President$5,665,896
Jeffrey CapelloExecutive Vice President and Chief Financial Officer$4,476,719

The full BIOGEN compensation record

free company brief

This page is one person within BIOGEN's record. The company brief lists every named executive, each linking to their own page.

Peer companies

named in the BIOGEN proxy · each links to its own free brief

Compensation, the day it’s disclosed

The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.

How this record is built

Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are BIOGEN's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.

Paul McKenzie's compensation dossier · One-time report. No refunds.